Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.
Saved in:
| Title: | Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. |
|---|---|
| Authors: | Gadelha MR; Neuroendocrinology Research Center/Endocrinology Division, Medical School and Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 21941-913, Brazil., Casagrande A; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA., Strasburger CJ; Department of Medicine for Endocrinology and Metabolic Disorders, Charité Universitaetsmedizin, Berlin 10117, Germany., Bidlingmaier M; Neuroendocrine Research Group, Department of Internal Medicine, Ludwig-Maximilians University, Munich 80336, Germany., Snyder PJ; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Guitelman MA; División Endocrinología, Hospital Carlos G. Durand, Buenos Aires 1405, Argentina., Boguszewski CL; Department of Internal Medicine, Endocrine Division (SEMPR), University Hospital, Federal University of Paraná, Curitiba 80030-110, Brazil., Buchfelder M; Neurosurgery Department, University Hospital Erlangen, Erlangen 91054, Germany., Shimon I; Rabin-Beilinson Medical Center, Institute of Endocrinology, Petach Tikva 4941492, Israel.; Faculty of Medical and Health Sciences, School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel., Raverot G; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Lyon Cedex 69002, France., Tóth M; Department of Internal Medicine and Oncology, Semmelweis University, Budapest 1083, Hungary., Mezősi E; Department of Medicine, University of Pécs Medical School, Pécs 7624, Hungary., Doknic M; Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia., Fan X; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA., Clemmons D; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514, USA., Trainer PJ; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA., Struthers RS; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA., Krasner A; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA., Biller BMK; Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, MA 02114, USA. |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Dec 18; Vol. 110 (1), pp. 228-237. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38828555 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gadelha+MR%22">Gadelha MR</searchLink>; Neuroendocrinology Research Center/Endocrinology Division, Medical School and Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 21941-913, Brazil.<br /><searchLink fieldCode="AU" term="%22Casagrande+A%22">Casagrande A</searchLink>; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Strasburger+CJ%22">Strasburger CJ</searchLink>; Department of Medicine for Endocrinology and Metabolic Disorders, Charité Universitaetsmedizin, Berlin 10117, Germany.<br /><searchLink fieldCode="AU" term="%22Bidlingmaier+M%22">Bidlingmaier M</searchLink>; Neuroendocrine Research Group, Department of Internal Medicine, Ludwig-Maximilians University, Munich 80336, Germany.<br /><searchLink fieldCode="AU" term="%22Snyder+PJ%22">Snyder PJ</searchLink>; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.<br /><searchLink fieldCode="AU" term="%22Guitelman+MA%22">Guitelman MA</searchLink>; División Endocrinología, Hospital Carlos G. Durand, Buenos Aires 1405, Argentina.<br /><searchLink fieldCode="AU" term="%22Boguszewski+CL%22">Boguszewski CL</searchLink>; Department of Internal Medicine, Endocrine Division (SEMPR), University Hospital, Federal University of Paraná, Curitiba 80030-110, Brazil.<br /><searchLink fieldCode="AU" term="%22Buchfelder+M%22">Buchfelder M</searchLink>; Neurosurgery Department, University Hospital Erlangen, Erlangen 91054, Germany.<br /><searchLink fieldCode="AU" term="%22Shimon+I%22">Shimon I</searchLink>; Rabin-Beilinson Medical Center, Institute of Endocrinology, Petach Tikva 4941492, Israel.; Faculty of Medical and Health Sciences, School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.<br /><searchLink fieldCode="AU" term="%22Raverot+G%22">Raverot G</searchLink>; Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, 'Groupement Hospitalier Est' Hospices Civils de Lyon, Lyon Cedex 69002, France.<br /><searchLink fieldCode="AU" term="%22Tóth+M%22">Tóth M</searchLink>; Department of Internal Medicine and Oncology, Semmelweis University, Budapest 1083, Hungary.<br /><searchLink fieldCode="AU" term="%22Mezősi+E%22">Mezősi E</searchLink>; Department of Medicine, University of Pécs Medical School, Pécs 7624, Hungary.<br /><searchLink fieldCode="AU" term="%22Doknic+M%22">Doknic M</searchLink>; Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia.<br /><searchLink fieldCode="AU" term="%22Fan+X%22">Fan X</searchLink>; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Clemmons+D%22">Clemmons D</searchLink>; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27514, USA.<br /><searchLink fieldCode="AU" term="%22Trainer+PJ%22">Trainer PJ</searchLink>; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Struthers+RS%22">Struthers RS</searchLink>; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Krasner+A%22">Krasner A</searchLink>; Crinetics Pharmaceuticals, Inc., San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Biller+BMK%22">Biller BMK</searchLink>; Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, MA 02114, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375362%22">The Journal of clinical endocrinology and metabolism</searchLink> [J Clin Endocrinol Metab] 2024 Dec 18; Vol. 110 (1), pp. 228-237. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0375362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1945-7197 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220021972X%22">0021972X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Endocrinol Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38828555 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1210/clinem/dgae385 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 228 Titles: – TitleFull: Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gadelha MR – PersonEntity: Name: NameFull: Casagrande A – PersonEntity: Name: NameFull: Strasburger CJ – PersonEntity: Name: NameFull: Bidlingmaier M – PersonEntity: Name: NameFull: Snyder PJ – PersonEntity: Name: NameFull: Guitelman MA – PersonEntity: Name: NameFull: Boguszewski CL – PersonEntity: Name: NameFull: Buchfelder M – PersonEntity: Name: NameFull: Shimon I – PersonEntity: Name: NameFull: Raverot G – PersonEntity: Name: NameFull: Tóth M – PersonEntity: Name: NameFull: Mezősi E – PersonEntity: Name: NameFull: Doknic M – PersonEntity: Name: NameFull: Fan X – PersonEntity: Name: NameFull: Clemmons D – PersonEntity: Name: NameFull: Trainer PJ – PersonEntity: Name: NameFull: Struthers RS – PersonEntity: Name: NameFull: Krasner A – PersonEntity: Name: NameFull: Biller BMK IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 12 Text: 2024 Dec 18 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1945-7197 Numbering: – Type: volume Value: 110 – Type: issue Value: 1 Titles: – TitleFull: The Journal of clinical endocrinology and metabolism Type: main |
| ResultId | 1 |